Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Actinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the
sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The purpose of this
study is to evaluate the safety of one, two, or three cycles of imiquimod for the treatment
of AK. The AK lesions treated can be in adjacent and nonadjacent areas of the head, torso,
and extremities. The total surface area for the AK lesions must be greater than 25 cm2. The
secondary objective is to evaluate the effectiveness of treatment with imiquimod in people
with large surface areas of AK.